Osaic Holdings
MBX

Osaic Holdings’s MBX Biosciences MBX Stock Holding History

Osaic Holdings’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.03K Sell
269
-77,332
-100% -$2.63M ﹤0.01% 6430
2025
Q4 		$2.45M Buy
+77,601
New +$1.88M ﹤0.01% 1916

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Osaic Holdings's MBX Position: Q1 2026 in Review

Osaic Holdings reduced its MBX Biosciences (MBX) stake by 100% in Q1 2026, selling an estimated $2.63M and leaving 269 shares worth $8.03K. The position accounts for ﹤0.01% of the portfolio, ranked #6430.

Osaic Holdings first reported a position in MBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.45M in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Osaic Holdings held 269 shares of MBX Biosciences worth $8.03K as of Q1 2026.
  • Osaic Holdings sold 77,332 MBX Biosciences shares in Q1 2026, an estimated $2.63M.
  • MBX Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6430 holding.
  • Osaic Holdings first reported a position in MBX Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Osaic Holdings's MBX Biosciences position peaked at $2.45M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.